• IMA sites
  • IMAJ services
  • IMA journals
  • Follow us
  • Alternate Text Alternate Text
עמוד בית
Sun, 26.05.24

CASE COMMUNICATIONS

IMAJ | volume 26

Journal 1, January 2024
pages: 49-51

Paraneoplastic Syndromes Masquerading as Autoimmune Disease

1 Department of Medicine C, Wolfson Medical Center, Holon, Israel 2 Department of Rheumatology, Wolfson Medical Center, Holon, Israel 3 Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Summary

Paraneoplastic syndromes are reported in 8–15% of patients diagnosed with cancer [1]. They are defined as syndromes that occur due to an underlying malignancy, which has yet to be diagnosed, or at the time of the diagnosis and less frequently following the diagnosis of a malignancy. Several mechanisms are involved including autocrine and paracrine mediators, hormones, peptides, cytotoxic lymphocytes, and cytokines [1,2].

Legal Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal or medical advice on any matter.
The IMA is not responsible for and expressly disclaims liability for damages of any kind arising from the use of or reliance on information contained within the site.
© All rights to information on this site are reserved and are the property of the Israeli Medical Association. Privacy policy

2 Twin Towers, 35 Jabotinsky, POB 4292, Ramat Gan 5251108 Israel